TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) is now available.
JOINN Laboratories has announced the composition of its board of directors and their respective roles within various committees. This update reflects the company’s commitment to structured governance and strategic oversight, which may enhance its operational efficiency and strengthen its position in the competitive pharmaceutical and biotechnology sector.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. operates within the pharmaceutical and biotechnology industry, focusing on research and development services. The company is known for its comprehensive laboratory services, contributing to advancements in drug development and safety evaluation.
Average Trading Volume: 5,004,863
Technical Sentiment Signal: Sell
Current Market Cap: HK$21.25B
Find detailed analytics on 6127 stock on TipRanks’ Stock Analysis page.

